UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients

AIDS (London), 2010-08, Vol.24 (13), p.2019-2027

2010

Volltextzugriff (PDF)

Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral-Naive Subjects

The Journal of infectious diseases, 2005-12, Vol.192 (11), p.1921-1930

2005

Volltextzugriff (PDF)

The ASSURE study: HIV‐1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir

HIV medicine, 2016-02, Vol.17 (2), p.106-117

2016

Volltextzugriff (PDF)

Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine

Journal of acquired immune deficiency syndromes (1999), 2006-11, Vol.43 (3), p.284-292

2006

Volltextzugriff (PDF)

Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks

HIV/AIDS (Auckland), 2017-01, Vol.9, p.51-61

2017

Volltextzugriff (PDF)

A prospective, 96‐week study of the impact of Trizivir®, Combivir®/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral‐naive patients: effect of sex and ethnicity

HIV medicine, 2006-03, Vol.7 (2), p.85-98

2006

Volltextzugriff (PDF)

Abacavir/lamivudine/zidovudine continues to be a valid and useful antiretroviral regimen

The Annals of pharmacotherapy, 2004-07, Vol.38 (7-8), p.1314-1316

Shaefer, Mark S

2004

Volltextzugriff (PDF)

Pharmacokinetics of tacrolimus in liver transplant patients

Clinical pharmacology and therapeutics, 1995-03, Vol.57 (3), p.281-290

1995

Volltextzugriff (PDF)

Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients

Journal of acquired immune deficiency syndromes (1999), 2003-10, Vol.34 (2), p.174-183

2003

Volltextzugriff (PDF)

Sex, Gender, and Orofacial Pain

The Dental clinics of North America, 2018-10, Vol.62 (4), p.665-682

2018

Volltextzugriff (PDF)

Reply to Carr

The Journal of infectious diseases, 2006-06, Vol.193 (12), p.1742-1743

2006

Volltextzugriff (PDF)

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

AIDS (London), 2000-04, Vol.14 (6), p.671-681

2000

Volltextzugriff (PDF)

Interprofessional Education for the Dentist in Managing Acute and Chronic Pain

The Dental clinics of North America, 2016-10, Vol.60 (4), p.825-842

2016

Volltextzugriff (PDF)

Pharmacodynamic Effects of Zidovudine 600 mg Once/Day versus 300 mg Twice/Day in Therapy-Naïve Patients Infected with Human Immunodeficiency Virus

Pharmacotherapy, 2004-03, Vol.24 (3), p.307-312

2004

Volltextzugriff (PDF)

Twice-Daily Triple Nucleoside Intensification Treatment with Lamivudine-Zidovudine plus Abacavir Sustains Suppression of Human Immunodeficiency Virus Type 1: Results of the TARGET Study

The Journal of infectious diseases, 2001-02, Vol.183 (4), p.571-578

2001

Volltextzugriff (PDF)

Correlation between self-reported Adherence to highly active antiretroviral therapy (HAART) and virologic outcome

Advances in therapy, 2001-07, Vol.18 (4), p.163-173

2001

Volltextzugriff (PDF)

Successful application of extracorporeal liver perfusion : a technology whose time has come

The American journal of gastroenterology, 1993-11, Vol.88 (11), p.1876-1881

1993

Volltextzugriff (PDF)

A prospective, 96-week study of the impact of Trizivir super( registered ), Combivir super( registered )-nelfinavir, and lamivudine-stavudine-nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity

HIV medicine, 2006-03, Vol.7 (2), p.85-98

2006

Volltextzugriff (PDF)

Twice-Daily Trizivir versus Combivir-Abacavir in Antiretroviral-Experienced Adults with Human Immunodeficiency Virus-1 Infection: A Formulation-Switch Trial

Pharmacotherapy, 2003-11, Vol.23 (11), p.1432-1440

2003

Volltextzugriff (PDF)

Pain and Temporomandibular Disorders

The Dental clinics of North America, 2013-04, Vol.57 (2), p.233-262

2013

Volltextzugriff (PDF)

Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients

Transplantation, 1991-01, Vol.51 (1), p.90-97

1991

Volltextzugriff (PDF)

Idiopathic thromboembolism associated with triphasic oral contraceptives

DICP (Cincinnati, Ohio), 1989-10, Vol.23 (10), p.773-775

1989

Volltextzugriff (PDF)

Current Topics in Immunotherapy and the Role of the Pharmacist on a Solid Organ Transplant Service

Pharmacotherapy, 1991-01, Vol.11 (6), p.136S-141S

Shaefer, Mark S.

1991

Volltextzugriff (PDF)

Evaluation of the pharmacokinetic interaction between cimetidine or famotidine and cyclosporine in healthy men

The Annals of pharmacotherapy, 1995-11, Vol.29 (11), p.1088

1995

Volltextzugriff (PDF)

Falsely elevated FK-506 levels caused by sampling through central venous catheters

Transplantation, 1993-08, Vol.56 (2), p.475-476

1993

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients

Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral-Naive Subjects

The ASSURE study: HIV‐1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir

Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine

Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks

A prospective, 96‐week study of the impact of Trizivir®, Combivir®/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral‐naive patients: effect of sex and ethnicity

Abacavir/lamivudine/zidovudine continues to be a valid and useful antiretroviral regimen

Pharmacokinetics of tacrolimus in liver transplant patients

Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients

Sex, Gender, and Orofacial Pain

Reply to Carr

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

Interprofessional Education for the Dentist in Managing Acute and Chronic Pain

Pharmacodynamic Effects of Zidovudine 600 mg Once/Day versus 300 mg Twice/Day in Therapy-Naïve Patients Infected with Human Immunodeficiency Virus

Twice-Daily Triple Nucleoside Intensification Treatment with Lamivudine-Zidovudine plus Abacavir Sustains Suppression of Human Immunodeficiency Virus Type 1: Results of the TARGET Study

Correlation between self-reported Adherence to highly active antiretroviral therapy (HAART) and virologic outcome

Successful application of extracorporeal liver perfusion : a technology whose time has come

A prospective, 96-week study of the impact of Trizivir super( registered ), Combivir super( registered )-nelfinavir, and lamivudine-stavudine-nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity

Twice-Daily Trizivir versus Combivir-Abacavir in Antiretroviral-Experienced Adults with Human Immunodeficiency Virus-1 Infection: A Formulation-Switch Trial

Pain and Temporomandibular Disorders

Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients

Idiopathic thromboembolism associated with triphasic oral contraceptives

Current Topics in Immunotherapy and the Role of the Pharmacist on a Solid Organ Transplant Service

Evaluation of the pharmacokinetic interaction between cimetidine or famotidine and cyclosporine in healthy men

Falsely elevated FK-506 levels caused by sampling through central venous catheters

Suchergebnisse filtern